
Genpharmasec Ltd Valuation Shifts to Fair Amidst Challenging Market Returns
2026-11-18 08:01:25Genpharmasec Ltd, a micro-cap player in the Trading & Distributors sector, has witnessed a notable shift in its valuation parameters, moving from an attractive to a fair rating. This change reflects evolving market perceptions amid subdued financial performance and challenging sector dynamics, prompting a reassessment of its price attractiveness relative to peers and historical benchmarks.
Read MoreGenpharmasec Surges 11.11% in a Week: Key Financial and Valuation Shifts Drive Momentum
2026-11-08 09:01:03Key Events This Week 2 Nov: Stock opens at Rs.1.02, up 3.03% 3 Nov: Continued gains with Rs.1.04 close (+1.96%) 4 Nov: Strong rally to Rs.1.09 (+4.81%) ahead of upgrades 5 Nov: Upgraded to Sell rating and valuation shift; stock closes at Rs.1.13 (+3.67%) 6 Nov: Minor correction to Rs.1.10 (-2.65%) despite Sensex rise Week OpenRs.0.99 ...
Read More
Genpharmasec Ltd Valuation Shifts Signal Changing Market Perception
2026-11-05 08:00:51Genpharmasec Ltd, a micro-cap player in the Trading & Distributors sector, has witnessed a notable shift in its valuation parameters, moving from a risky to a fair valuation grade. This change, coupled with its recent price movements and peer comparisons, offers investors a fresh perspective on the stock’s price attractiveness amid a challenging market backdrop.
Read More
Genpharmasec Ltd is Rated Strong Sell
2026-10-14 10:10:27Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 14 October 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.
Read More
Genpharmasec Ltd is Rated Strong Sell
2026-09-29 10:10:03Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics presented here reflect the stock’s current position as of 29 September 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.
Read More
Genpharmasec Ltd is Rated Strong Sell
2026-09-17 10:10:04Genpharmasec Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 22 May 2025. However, the analysis and financial metrics discussed below reflect the company’s current position as of 17 September 2026, providing investors with an up-to-date view of the stock’s fundamentals, valuation, financial trend, and technical outlook.
Read More
Genpharmasec Ltd is Rated Strong Sell
2026-09-04 10:10:27Genpharmasec Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 22 May 2025, reflecting a shift from a previous 'Sell' grade. However, the analysis and financial metrics discussed here represent the stock's current position as of 04 September 2026, providing investors with an up-to-date view of the company's fundamentals, returns, and market standing.
Read MoreAnnouncement under Regulation 30 (LODR)-Newspaper Publication
05-Nov-2026 | Source : BSENewspaper Publication of Unaudited Financial Results for the quarter and half year ended September 30 2026.
Statement Of Deviation Or Variation In The Use Of Proceeds Of Rights Issue For The Quarter Ended 30Th September 2026.
03-Nov-2026 | Source : BSEStatement of deviation or variation in the use of proceeds of Rights Issue for the Quarter ended 30th September 2026.
Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer
03-Nov-2026 | Source : BSEOutcome of the Meeting of Board of Directors held on Tuesday 03rd November 2026.
Corporate Actions
No Upcoming Board Meetings
No Dividend history available
Genpharmasec Ltd has announced 1:10 stock split, ex-date: 11 Apr 19
No Bonus history available
Genpharmasec Ltd has announced 1:1 rights issue, ex-date: 09 Jan 24